Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed267%
unknown133%

Recent Activity

0 active trials
Showing 3 of 3
completed

Efficacy and Safety of the Minimed 780G® Advanced Hybrid Closed Loop System (AHCL) in Patients With Type 1 Diabetes Undergoing Surgery

NCT06947031
completednot_applicable

ADvanced Hybrid Closed Loop Study in Adult Population With Type 1 Diabetes

NCT04235504
unknownnot_applicable

Assessment of Two Insulin Pump Insulin Delivery Systems in Type 1 Diabetes.

NCT04073576

Clinical Trials (3)

Showing 3 of 3 trials
NCT06947031

Efficacy and Safety of the Minimed 780G® Advanced Hybrid Closed Loop System (AHCL) in Patients With Type 1 Diabetes Undergoing Surgery

Completed
NCT04235504Not Applicable

ADvanced Hybrid Closed Loop Study in Adult Population With Type 1 Diabetes

Completed
NCT04073576Not Applicable

Assessment of Two Insulin Pump Insulin Delivery Systems in Type 1 Diabetes.

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3